This inventor holds 1 USPTO granted patent. Top assignee: Aeras Global Tb Vaccine Foundation. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Michele Stone: Innovating Bacterial Packaging for RNA-Based Therapeutics
Introduction
Michele Stone, an accomplished inventor based in Ellicott City, Maryland, has made significant contributions to the field of biotechnology. With a focus on innovations that aid in the generation and production of recombinant double-stranded RNA nucleocapsids, she holds a patent that showcases her expertise and passion for improving therapeutic solutions.
Latest Patents
Michele Stone's notable patent is titled "Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof." This patented technology provides packaging strains that are essential for producing RNA encoding vaccine antigens, bioactive proteins, immunoregulatory proteins, antisense RNAs, and catalytic RNAs in eukaryotic cells or tissues. By introducing recombinant ssRNA into these strains, the technology enables the packaging of rdsRNs de novo, advancing possibilities in RNA-based therapies.
Career Highlights
Currently, Michele is associated with the Aeras Global TB Vaccine Foundation, where her work revolves around innovative solutions to combat tuberculosis through advanced research and technology. Her dedication to improving public health through scientific methods sets her apart in her field.
Collaborations
Michele collaborates with notable colleagues, including David M. Hone and John Fulkerson, enhancing the impact of her research and fostering innovation in the development of vaccines and therapeutic proteins. Together, they contribute to a progressive environment that encourages breakthrough discoveries.
Conclusion
With her groundbreaking patent and commitment to advancing biotechnology, Michele Stone is a standout inventor in the realm of RNA therapeutics. Her work not only contributes to scientific knowledge but also paves the way for future innovations that could lead to significant improvements in vaccine development and treatment strategies. Through her efforts, Michele exemplifies the essential role inventors play in the intersection of science and public health.